HIV postexposure prophylaxis for children and adolescents.

[1]  D. Henderson.  Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. , 1999, JAMA.

[2]  R. Heimer,et al.  Survival of HIV-1 in syringes. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  J. Gerberding,et al.  The Care of Persons with Recent Sexual Exposure to HIV , 1998, Annals of Internal Medicine.

[4]  G. Ippolito,et al.  Zidovudine toxicity in uninfected healthcare workers , 1997 .

[5]  J. Gerberding,et al.  Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. , 1997, The New England journal of medicine.

[6]  K. Butler,et al.  Childhood needlestick injuries in the Dublin metropolitan area. , 1997, Irish medical journal.

[7]  R. Haug.  Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. , 1997, MMWR. Morbidity and mortality weekly report.

[8]  J. Bartlett,et al.  Medical Management of HIV Infection , 1996 .

[9]  I. de Vincenzi,et al.  Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[10]  I. de Vincenzi,et al.  Probabilities of sexual HIV‐1 transmission , 1996, AIDS.

[11]  R. Grant,et al.  Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine , 1995, Science.

[12]  W. Shearer,et al.  ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY IN CHILDREN WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1995, Pediatrics.

[13]  G. Forseter,et al.  Tolerability, safety, and acceptability of zidovudine prophylaxis in health care workers. , 1994, Archives of internal medicine.

[14]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[15]  M. Uhlén,et al.  Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes , 1994, Journal of virology.

[16]  J. Wyatt,et al.  Out of hospital needlestick injuries. , 1994, Archives of disease in childhood.

[17]  J. Tokars,et al.  Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-Infected Blood , 1993, Annals of Internal Medicine.

[18]  E H Kaplan,et al.  A model-based estimate of HIV infectivity via needle sharing. , 1992, Journal of acquired immune deficiency syndromes.

[19]  J. McCune,et al.  Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. , 1991, The Journal of infectious diseases.